UoH incubator and Indian Immunologicals sign MoU

Life Sciences incubation centre at the University of Hyderabad, ASPIRE-BioNEST, and Indian Immunologicals Ltd, signed an MoU to advance innovation under the One Health framework on Friday.

World Health Organisation’s ‘One Health’ is an integrated approach to balance and optimise the health of people, animals and the environment, to prevent, predict, detect, and respond to global health threats like the COVID-19 pandemic. It involves public health, veterinary, and environmental sectors.

The partnership will support startups working in fields of therapies, diagnostics, medical devices, and allied technologies, with a focus on translational research and commercialisation. It will enable co-development, validation, technology transfer, and market access for products of mutual interest, and bridging the gap between innovation and real-world deployment. The collaboration is expected to enhance the speed and success rate of translating early-stage innovations into deployable biotech products, an official release stated.

Director (IIL) K. Anand Kumar and Director (ASPIRE-BioNEST) S. Rajagopal, and officials from the organisations participated in the signing ceremony.

Under the MoU, startups will benefit from IIL’s technical mentorship and domain expertise, along with access to advanced process development and analytical facilities, including capabilities relevant to viral and bacterial vaccine development. They will jointly organise initiatives such as hackathons, pre-incubation programmes, seminars, and conferences to promote entrepreneurship.